We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Civco Medical Instruments

Designs and manufactures accessories for use in diagnostic and therapeutic imaging, ranging from infection control pr... read more Featured Products: More products

Download Mobile App




CIVCO Medical Solutions Introduces Next-Generation of Ultrasound Accessories

By HospiMedica International staff writers
Posted on 23 Nov 2018
CIVCO Medical Solutions (Coralville, IA, USA) presented Envision – the next generation of ultrasound probe covers and scan pads – at the 2018 Radiological Society of North America (RSNA) annual meeting, November 25-30 in Chicago, Ill., USA.

CIVCO designs and manufactures accessories for use in diagnostic and therapeutic imaging and interventional procedures with a focus on ultrasound. More...
The company’s specialties include infection control (ultrasound probe and system covers), high-level disinfection of ultrasound probes, needle and device guidance, electromagnetic needle tracking, and transperineal prostate solutions.

Envision ultrasound probe covers and scan pads are viral barriers allowing for 100% gel-free ultrasound procedures. The Envision ultrasound probe cover and scan pad enable physicians and clinicians to simplify workflow throughout a procedure. Radiology physicians and clinicians can activate Envision with a sterile liquid to perform ultrasound procedures, thus eliminating the need for gel. A quick-peel, silicone liner adheres safely to the probe face or to the patient’s skin, while a sterile liquid, such as sterile saline, can be applied to the Envision cover or pad, or directly on the patient’s skin, before beginning scanning. Thus, pre-cleaning of the ultrasound probe is simplified without gel, before sending to high-level disinfection.

The elimination of gel from procedures utilizing Envision can improve the quality of fine needle aspiration (FNA) specimens, reduces the risk of contamination and simplifies workflow. By eliminating the need for gel from these procedures, Envision covers can help improve the visibility of cells in FNAs. The removal of gel when using Envision can help reduce the risk of contamination during needle-guided ultrasound interventions or while scanning non-intact skin.


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Pediatric Mask
Respire SOFT
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.